Viewing Study NCT05209256


Ignite Creation Date: 2025-12-24 @ 11:31 PM
Ignite Modification Date: 2026-01-02 @ 12:00 AM
Study NCT ID: NCT05209256
Status: UNKNOWN
Last Update Posted: 2022-01-26
First Post: 2022-01-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Alflutinib Versus Alflutinib Plus Chemotherapy for NSCLC
Sponsor: The First Affiliated Hospital of Henan University of Science and Technology
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None NSCLC View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NSCLC ,EGFR(T790M),alflutinib View